2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Kristen P. Bunch, DO

Research Fellow
National Cancer Institute
9609 Medical Center Drive
Bethesda, MD
USA 20892-9760

Papers:
517 High-throughput matrix screening in ovarian cancer cells identifies synergistic drug combinations with the second mitochondrial-derived activator of caspases (SMAC) mimetic birinapant (TL32711)